A significant decrease was also observed in the percentage of MHCII+, CD80+, CD86+, and CD40+ DCs in the LY294002-treated mice compared with that in the LPS-induced ALI mice (Figures 4A,B). This evidence concerns the gene CD40 and acute respiratory distress syndrome.